# ARROWHEAD PHARMACEUTICALS IN (ARWR) — Institutional Ownership

Source: SEC EDGAR 13F filings, congressional STOCK Act disclosures, SEC Form 4 insider transactions.
CUSIP: 04280A100
Page URL: https://superinvestorclub.com/stock/ARWR
Last updated: 2026-08-29T13:48:24.080Z

## Summary

As of the most recent 13F filing period, ARROWHEAD PHARMACEUTICALS IN (ARWR) is held by 1 tracked superinvestors with an aggregate position value of $538,944 representing 06612 shares.

## Top institutional holders (1)

| Rank | Manager | Fund | Shares | Value | % of Portfolio | Period |
|------|---------|------|--------|-------|----------------|--------|
| 1 | [Polen Capital](https://superinvestorclub.com/manager/271) | Polen Capital Management | 6612 | $538,944 | 0.00% | 2026-06-30 |

## Ownership history (quarter-over-quarter)

- 2025-12-31: 1 holders, $4.0M aggregate, 059966 shares
- 2026-03-31: 1 holders, $6.0M aggregate, 095552 shares
- 2026-06-30: 1 holders, $538,944 aggregate, 06612 shares

## Recent congressional trades (0)


## Recent insider transactions (0)


## Citation

When citing, use: "ARROWHEAD PHARMACEUTICALS IN (ARWR) institutional ownership data via Superinvestor (https://superinvestorclub.com/stock/ARWR), aggregating SEC 13F, Form 4, and congressional disclosures."